Amicus Therapeutics Inc
F:AM6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amicus Therapeutics Inc
F:AM6
|
US |
|
Kutcho Copper Corp
F:1QV
|
CA |
|
C
|
China New City Commercial Development Ltd
F:C7B
|
CN |
|
X
|
Xigem Technologies Corp
CNSX:XIGM
|
CA |
|
Bank Mestika Dharma Tbk PT
IDX:BBMD
|
ID |
|
Biotron Ltd
ASX:BIT
|
AU |
|
G
|
Greenheart Gold Inc
XTSX:GHRT
|
CA |
|
Open Orphan PLC
F:CRO
|
UK |
|
S
|
Solid Automotive Bhd
KLSE:SOLID
|
MY |
|
Bango PLC
F:B1O
|
UK |
|
Adaptive Ad Systems Inc
OTC:AATV
|
US |
|
Medivir AB
F:MVR
|
SE |
|
H
|
Huntington Exploration Inc
OTC:HEXPF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AM6's stock price target?
Not Available
AM6 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Amicus Therapeutics Inc?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 3 years is 20%.
What is the Gross Profit forecast for Amicus Therapeutics Inc?
Projected CAGR
21%
The compound annual growth rate for Gross Profit over the next 3 years is 21%.
What is the Operating Income forecast for Amicus Therapeutics Inc?
Projected CAGR
124%
The compound annual growth rate for Operating Income over the next 3 years is 124%.
What is the Pre-Tax Income forecast for Amicus Therapeutics Inc?
Projected CAGR
1 108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 1 108%.
